Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome (Q44034235)

29 November 2017

Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome (English)

1 reference

29 November 2017

0 references

F Gutiérrez

1

1 reference

29 November 2017

M Masiá

2

1 reference

29 November 2017

J C Rodríguez

3

1 reference

29 November 2017

C Mirete

4

1 reference

29 November 2017

B Soldán

5

1 reference

29 November 2017

S Padilla

6

1 reference

29 November 2017

I Hernández

7

1 reference

29 November 2017

G Royo

8

1 reference

29 November 2017

A Martin-Hidalgo

9

1 reference

29 November 2017

1 June 2005

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

29 November 2017

1 reference

29 November 2017

24

1 reference

29 November 2017

6

1 reference

29 November 2017

377-383

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-005-1346-2

29 November 2017

0 references

cites work

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-1346-2

The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-1346-2

Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-1346-2

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10096-005-1346-2

21 January 2018

12 December 2020

Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. CBPIS Study Group. Community-based Pneumonia Incidence Study

1 reference

https://api.crossref.org/works/10.1007%2FS10096-005-1346-2

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

21 January 2018

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Chlamydia species as a cause of community-acquired pneumonia in Canada

1 reference

12 December 2020

Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.

1 reference

12 December 2020

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

1 reference

12 December 2020

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

12 December 2020

Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children

1 reference

12 December 2020

Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia

1 reference

12 December 2020

Etiology of community-acquired pneumonia in patients requiring hospitalization

1 reference

12 December 2020

Urinary excretion of pneumococcal cell wall polysaccharide in children

1 reference

12 December 2020

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

12 December 2020

Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study

1 reference

12 December 2020

Community-acquired pneumonia. A prospective outpatient study

1 reference

12 December 2020

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

1 reference

12 December 2020

What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?

1 reference

12 December 2020

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

12 December 2020

Epidemiology of community-acquired pneumonia in adults: a population-based study

1 reference

12 December 2020

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

1 reference

12 December 2020

Viral potentiation of bacterial superinfection of the respiratory tract

1 reference

12 December 2020

Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states : 1993, 1995, and 1997.

1 reference

12 December 2020

The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD

1 reference

12 December 2020

Bacterial Pneumonia During the Hong Kong Influenza Epidemic of 1968-1969

1 reference

12 December 2020

The cost of treating community-acquired pneumonia.

1 reference

12 December 2020

Microbial etiology of acute pneumonia in hospitalized patients

1 reference

12 December 2020

Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals

1 reference

12 December 2020

Etiology of community-acquired pneumonia in out-patients

1 reference

12 December 2020

Etiology of childhood pneumonia: serologic results of a prospective, population-based study

1 reference

12 December 2020

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

12 December 2020

The emerging role of atypical pathogens in community-acquired pneumonia

1 reference

12 December 2020

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

12 December 2020

Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients

1 reference

12 December 2020

A role for Streptococcus pneumoniae in virus-associated pneumonia

1 reference

12 December 2020

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

1 reference

12 December 2020

Importance of atypical pathogens of community-acquired pneumonia

1 reference

12 December 2020

10.1007/S10096-005-1346-2

Identifiers

DOI

1 reference

29 November 2017

1 reference